_Coconut_beach.jpg)
Burundi: recent disease outbreaks
Sources checked
Recent reports
Cholera (Vibrio cholerae) — ongoing transmission in Burundi
WHO’s Weekly Epidemiological Record and WHO regional reports show that cholera/acute watery diarrhoea (AWD) transmission in Burundi remained active during 2026; WHO reported 1,868 cumulative cholera/AWD cases and 4 deaths in Burundi for January–August 2026 and recorded 201 cases in the most recent 28‑day window (data cut‑off 30 August 2026). WHO WER (Vol.101, Issue 39, 2 Oct 2026). This is a human‑only event (cases are people) and matters to travellers because cholera causes acute watery diarrhoea and can spread where water, sanitation and hygiene (WASH) are inadequate; WHO and partners continue WASH and case‑management activities in affected areas. WHO WER (cholera update).
Measles — clusters linked to refugee populations and local transmission
WHO Regional Office for Africa reported active measles transmission affecting communities and refugee settlements in eastern Burundi, and described reactive vaccination campaigns to protect children in Congolese refugee camps (vaccination activities reported January 20–25, 2026). WHO AFRO, 6 Jul 2026. More recent regional surveillance compiled by Africa CDC lists Burundi among countries with ongoing measles activity and reports 1,411 suspected cases with 13 deaths in the item dated 20 September 2026 (Africa CDC weekly reporting). Africa CDC (situation report, 20 Sep 2026). This is human‑to‑human transmission (respiratory spread) and is of particular concern for unvaccinated children or travellers in contact with local communities or refugee camps; WHO/partners have been running targeted vaccination and surveillance in affected districts. WHO AFRO.
Mpox (monkeypox, clade Ib) — sustained but declining detection; surveillance ongoing
Burundi reported transmission of mpox (clade Ib) during 2024–2026 and has been included in WHO mpox situational reporting and regional monitoring; WHO weekly epidemiological reporting during September–October 2026 continued to list mpox among signals under observation in the African Region. WHO WER (Issue 38/39, Sep–Oct 2026). Recent peer‑reviewed analysis of cases in Bujumbura (published Sept 2026) describes local transmission dynamics during the earlier part of the outbreak and documents diagnostic scale‑up in Burundi. Journal article (Sep 2026). The available evidence indicates ongoing surveillance and response rather than an explosive new surge; this is a human viral infection and remains relevant for travellers because clinical presentation can be variable and laboratory confirmation guides public‑health actions. WHO WER.
Ebola (regional Bundibugyo virus outbreak) — cross‑border risk and entry screening measures in Burundi
An Ebola (Bundibugyo ebolavirus) outbreak in neighbouring countries (DRC, Uganda and others) prompted Burundi to maintain enhanced preparedness and point‑of‑entry surveillance in 2026. WHO’s weekly reporting recorded new Ebola Disease News items for the region in late 2026, and United Nations / partner updates in August 2026 and Burundi government communications in October 2026 describe strengthened screening and readiness activities at borders and airports. WHO WER (2 Oct 2026); UN / partner update (26 Aug 2026); Burundi embassy note (14 Oct 2026). Public reporting and Burundi authorities describe measures that have been implemented or reinforced at entry points: traveller health/declaration forms, temperature checks and syndromic screening for travellers from affected countries (measures apply specifically to arrivals from or recently in Ebola‑affected areas). UN / Burundi reports.
Summary
These entries are a dated snapshot (sources checked 27 October 2026). Conditions can change quickly; travellers should consult the country health guide and the destination’s public‑health authority, and check WHO/Africa CDC and their own government travel health advice for up‑to‑date requirements (for example temporary entry screening or vaccination documentation) before and during travel.